Group structure
6 companies in 4 countries
Italy1
Malaysia1
Thailand1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Loading…
6 companies in 4 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1–25 of 495
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABLOK | Atenolol | Brazil | Authorised | 2000 |
| ABLOK PLUS | Atenolol, Chlorthalidone | Brazil | Authorised | 1999 |
| ácido ursodesoxicólico | Ácido ursodesoxicólico | Brazil | Authorised | 2024 |
| ácido valpróico | Valproic acid | Brazil | Authorised | 2018 |
| AD-MUC | Matricaria recutita l. | Brazil | Authorised | 2003 |
| AGUD | Paracetamol, Codeine | Brazil | Authorised | 2018 |
| alfaestradiol | Alfaestradiol | Brazil | Authorised | 2020 |
| ALOZEX | Alfaestradiol | Brazil | Authorised | 2018 |
| apixabana | Apixaban | Brazil | Authorised | 2025 |
| ARADOIS | Losartan | Brazil | Authorised | 2001 |
| ARADOIS H | Losartan, Hydrochlorothiazide | Brazil | Authorised | 2001 |
| atenolol | Atenolol | Brazil | Authorised | 2018 |
| ATEROGREL | Clopidogrel | Brazil | Authorised | 2011 |
| ATIVB | Mecobalamin | Brazil | Authorised | 2022 |
| benfotiamina | Benfotiamina | Brazil | Authorised | 2023 |
| BESILATO DE ANLODIPINO | Anlodipino | Brazil | Authorised | 2021 |
| besilato de levanlodipino | Levanlodipino | Brazil | Authorised | 2015 |
| BHENA | Benazepril | Brazil | Authorised | 2020 |
| BILYT | Lithium | Brazil | Authorised | 2021 |
| BIOLME | Olmesartan medoxomilo | Brazil | Authorised | 2025 |
| BIOLME H | Olmesartan medoxomilo, Hydrochlorothiazide | Brazil | Authorised | 2025 |
| bissulfato de clopidogrel | Clopidogrel | Brazil | Authorised | 2021 |
| BIVOLET | Nebivolol | Brazil | Authorised | 2021 |
| bosentana | Bosentan | Brazil | Authorised | 2021 |
| bromidrato de citalopram | Citalopram | Brazil | Authorised | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 494 | 187 | 307 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, Italy, Malaysia, Singapore
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Keep Biolab’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callContains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.